Assessing Atopic Dermatitis Severity in Clinical Practice
The clinical value of a composite measure of IGA and BSA (IGAxBSA) in measuring the severity of atopic dermatitis is reviewed.
The clinical value of a composite measure of IGA and BSA (IGAxBSA) in measuring the severity of atopic dermatitis is reviewed.
Risk for severe acne lower for atopic dermatitis patients than controls, with the reduced risk driven by adolescents, young adults
The association between hand eczema and occupational and nonoccupational wet exposure is explored.
New AAD guidelines seek to raise awareness of comorbid disorders in patients with atopic dermatitis among dermatologists and other clinicians.
Researchers sought to summarize scientific data on ocular surface disease in patients with atopic dermatitis receiving treatment with dupilumab.
Prevalence and sex differences of young adults with atopic dermatitis (AD) are characterized.
Hospitalization rates of adults with moderate to severe atopic dermatitis (AD) treated with dupilumab vs control patients are compared.
The sBLA is supported by data from the phase 3 LIBERTY AD PRESCHOOL study.
The occlusive abilities of different vegetable oils commonly used in skincare cosmetics are assessed.
Worsening reported in eczema area and severity index score, numerical rating scale worst itch, and dermatology life quality index